Science Explorer Back to mapMap
Discussion
Company · Chuncheon · South Korea

EuBiologics (South Korea)

Research works
33
▲ 53% vs 2018-21
Citations
311
9.3 per fractional work
Top-10% rate
12.3%
all institutions 10.0%
Open access
64%
world 40%
International
17%
world 18%

Not ranked overall: EuBiologics (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does EuBiologics (South Korea) work in?

In all years, 48% of research at EuBiologics (South Korea) is in Life Sciences, 45% in Health Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (15%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 16 fractional works · 48.0% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 24.7% of its workMolecular Biology: 4 fractional works · 13.1% of its workEndocrinology: 3 fractional works · 7.7% of its workCell Biology: 1 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.0% of its workBiotechnology: 0 fractional works · 0.7% of its workCancer Research: 0 fractional works · 0.5% of its workImmunology and Microbiology: 5 fractional works · 15.4% of its workImmunology: 4 fractional works · 12.8% of its workMicrobiology: 1 fractional works · 2.6% of its workAgricultural and Biological Sciences: 2 fractional works · 5.0% of its workFood Science: 1 fractional works · 2.8% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.0% of its workPlant Science: 0 fractional works · 0.8% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 2.2% of its workNeurology: 1 fractional works · 2.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workHealth Sciences: 15 fractional works · 45.4% of its workMedicine: 15 fractional works · 43.7% of its workEpidemiology: 3 fractional works · 8.4% of its workOncology: 2 fractional works · 7.3% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 5.7% of its workInfectious Diseases: 2 fractional works · 5.1% of its workDermatology: 1 fractional works · 4.0% of its workComplementary and alternative medicine: 1 fractional works · 2.5% of its workPathology and Forensic Medicine: 1 fractional works · 2.5% of its workPhysiology: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workRheumatology: 0 fractional works · 1.2% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.1% of its workReproductive Medicine: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.7% of its workGastroenterology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 1.5% of its workNutrition and Dietetics: 1 fractional works · 1.5% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 5.5% of its workEngineering: 1 fractional works · 3.6% of its workBiomedical Engineering: 1 fractional works · 2.6% of its workComputational Mechanics: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workOcean Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.7% of its workEcology: 0 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.5% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.2% of its workBiomaterials: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 0.9% of its workHealth: 0 fractional works · 0.5% of its workTransportation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKEuBiologics(South Korea)33fractional works, all years
Life Sciences48%Physical Sciences5%Health Sciences45%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology824.7%
    2. Immunology and Microbiology515.4%
    3. Agricultural and Biological Sciences25.0%
    4. Neuroscience12.2%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Medicine1543.7%
    2. Nursing11.5%
    3. Veterinary00.2%
    1. Engineering13.6%
    2. Environmental Science11.7%
    3. Materials Science00.2%
    1. Social Sciences00.9%
    2. Business, Management and Accounting00.1%
    3. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.10× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.64× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 13.52× its world share, 3 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.58× its world share, 0 worksPharmacology, Toxico…Engineering: 0.29× its world share, 1 worksEngineeringEnvironmental Science: 0.34× its world share, 0 worksEnvironmental ScienceMedicine: 2.37× its world share, 9 worksMedicineNursing: 4.85× its world share, 0 worksNursingVeterinary: 3.14× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Social Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.5×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology13.52×3 works
  2. Nursing4.85×0 works
  3. Biochemistry, Genetics and Molecular Biology4.64×5 works
  4. Veterinary3.14×0 works
  5. Pharmacology, Toxicology and Pharmaceutics2.58×0 works
  6. Medicine2.37×9 works
  7. Agricultural and Biological Sciences1.10×1 works
  8. Environmental Science0.34×0 works
  9. Engineering0.29×1 works
  10. Neuroscience0.26×0 works
  11. Business, Management and Accounting0.08×0 works
  12. Social Sciences0.03×0 works

Who are the top researchers at EuBiologics (South Korea)?

Ranked on the quality score, Yeong Ok Baik, Seuk Keun Choi and Chankyu Lee lead among researchers whose main affiliation is EuBiologics (South Korea).

  1. 1 Yeong Ok Baik South Korea · #3,057,055 worldwide 246 citations · 21 works
  2. 2 Seuk Keun Choi South Korea · #4,300,829 worldwide 218 citations · 16 works
  3. 3 Chankyu Lee South Korea · #5,354,083 worldwide 293 citations · 49 works
All ranked researchers at EuBiologics (South Korea)

What are the most cited papers from EuBiologics (South Korea)?

The most cited paper from EuBiologics (South Korea) is "Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion" (Jongoh Shin, Jung‐Ran Noh, Dong‐Ho Chang et al., 2019), with 119 citations. Next come "Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis" (102) and "The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships" (86).

Most cited papers
#PaperReleasedCitations
1 Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion Jongoh Shin, Jung‐Ran Noh, Dong‐Ho Chang et al. · Frontiers in Microbiology Open access 22 May 2019 119
2 Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis Su‐Man Kim et al. · Cell Host & Microbe Open access Jun 2023 102
3 The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships Lina Odevall, Deborah Y. Q. Hong, Laura C. Digilio et al. · Vaccine Open access Oct 2018 86
4 A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines Yeong Ok Baik, Seuk Keun Choi, Remigio M. Olveda et al. · Vaccine 5 Sep 2015 67
5 Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply Sonia R. Pagliusi, Stephen Jarrett, Benoit Hayman et al. · Vaccine Open access 11 Jun 2020 60
All 73 most cited papers, with filters and sorting

Which keywords describe research at EuBiologics (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine Development, Glycosylation, Monoclonal Antibodies, Antimicrobial Resistance, Vaccine and Innate Immunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology7▲ 5.5×18 topics
  2. Pathogenesis3▲ 15×8 topics
  3. Vaccine Development2▲ 25×6 topics
  4. Glycosylation2▲ 33×3 topics
  5. Monoclonal Antibodies2▲ 48×3 topics
  6. Antimicrobial Resistance2▲ 26×5 topics
  7. Vaccine2▲ 16×7 topics
  8. Immunity2▲ 18×4 topics
  9. Innate Immunity2▲ 18×4 topics
  10. Gut Microbiota2▲ 18×4 topics
  11. Oxidative Stress2▲ 3.3×9 topics
  12. Therapeutic Antibodies2▲ 46×2 topics
  13. Antibody Engineering2▲ 56×1 topic
  14. Cancer Immunotherapy2▲ 41×2 topics
  15. Fc Receptors2▲ 56×1 topic
  16. Inflammation2▲ 2.2×10 topics
  17. Pathogenicity2▲ 57×2 topics
  18. Antibiotic Resistance2▲ 12×3 topics
  19. Virulence2▲ 63×2 topics
  20. Probiotics1▲ 17×2 topics
  21. Genomic Analysis1▲ 13×2 topics
  22. Immunotherapy1▲ 5.8×4 topics
  23. Infection1▲ 14×3 topics
  24. Pandemic1▲ 8.3×3 topics
  25. Cytokines1▲ 14×2 topics
  26. Escherichia coli1▲ 159×1 topic
  27. Immune Response1▲ 5.9×7 topics
  28. Shiga toxin1▲ 159×1 topic
  29. Tumor Regression1▲ 40×2 topics
  30. Antioxidant Activity1▲ 6.0×3 topics
  31. Aquaculture1▲ 12×1 topic
  32. Cholera1▲ 124×1 topic
  33. Fish Immunology1▲ 70×1 topic
  34. Genomics1▲ 9.3×2 topics
  35. Vibrio cholerae1▲ 124×1 topic
  36. Virus1▲ 27×2 topics
  37. Antigen Presentation1▲ 31×2 topics
  38. CAR T Cells1▲ 70×1 topic
  39. Chimeric Antigen Receptor1▲ 70×1 topic
  40. Staphylococcus aureus1▲ 40×2 topics

Which research topics does EuBiologics (South Korea) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Aquaculture disease management and microbiota and Advanced Biosensing Techniques and Applications.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Aquaculture disease management and microbiota Immunology 1 works
  4. 4 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
  5. 5 Skin Protection and Aging Dermatology 1 works
  6. 6 Dermatology and Skin Diseases Dermatology 1 works
  7. 7 Reproductive System and Pregnancy Immunology 1 works
  8. 8 TGF-β signaling in diseases Molecular Biology 0 works
  9. 9 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  10. 10 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.5%not open36.5%

World: 40% of research is openly available.

with international co-authors17.4%domestic only82.6%

World: 18% is written across borders.

How has EuBiologics (South Korea)'s research output changed?

Output in 2022-2025 was 53% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is EuBiologics (South Korea) as a percentage of every work published that year, 0.000084% in 2024.

still counting0.000050%0.00010%EuBiologics (South Korea)0.000054% in 202520102020

Fractional works of EuBiologics (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Chuncheon

All research institutions in Chuncheon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about EuBiologics (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.